BCC
ETON icon

Bridge City Capital’s Eton Pharmaceutcials ETON Stock Holding History

Bridge City Capital’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$522K Buy
21,150
+2,550
+14% +$44.6K 0.14% 97
2025
Q4 		$315K Buy
18,600
+1,927
+12% +$33.9K 0.09% 103
2025
Q3 		$362K Buy
+16,673
New +$277K 0.1% 97

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Bridge City Capital's ETON Position: Q1 2026 in Review

Bridge City Capital increased its Eton Pharmaceutcials (ETON) stake by 14% in Q1 2026, buying an estimated $44.6K and bringing the position to 21,150 shares worth $522K. The position accounts for 0.14% of the portfolio, ranked #97.

Bridge City Capital first reported a position in ETON in Q3 2025 and has held it in 3 quarters since. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Bridge City Capital held 21,150 shares of Eton Pharmaceutcials worth $522K as of Q1 2026.
  • Bridge City Capital bought 2,550 Eton Pharmaceutcials shares in Q1 2026, an estimated $44.6K.
  • Eton Pharmaceutcials made up 0.14% of Bridge City Capital's portfolio in Q1 2026, its #97 holding.
  • Bridge City Capital first reported a position in Eton Pharmaceutcials in Q3 2025 and has held it in 3 quarters since.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Bridge City Capital's 13F filing for Q1 2026, filed 13 May 2026.